{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:09:32Z","timestamp":1794258572234,"version":"4.9.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1118"],"award-info":[{"award-number":["CRC 1118"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["517361638"],"award-info":[{"award-number":["517361638"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["25ZR1402320"],"award-info":[{"award-number":["25ZR1402320"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sphingosine-1-phosphate (S1P) is a crucial sphingolipid mediator in vasculature and neovascular eye diseases by controlling angiogenesis, inflammation and fibrosis. Five S1P receptors (S1PRs) are key therapeutic targets, with several S1PR-targeted drugs already in clinical use or trials. However, the vascular function of its major metabolic product, the reactive lipid aldehyde 2-hexadecenal (2-HD), remains unexplored. Here, we show that loss of the aldehyde dehydrogenase ALDH3B1 impairs 2-HD detoxification and leads to retinal vascular abnormalities in zebrafish, without affecting the trunk vasculature. Mechanistically, multi-omics analyses reveal that 2-HD accumulation disrupts iron homeostasis and induces ferroptosis by directly interacting with S1PR5. This finding is supported by integrative analyses of single-cell RNA sequencing and RNA sequencing from human neovascular retinal samples, identifying S1PR5 as a clinically relevant target. These findings uncover a previously unrecognized role of S1P derived 2-HD in vasculature and retinal vascular homeostasis, suggesting that targeting S1PR5 could offer a therapeutic strategy for diabetic retinopathy.<\/jats:p>","DOI":"10.1038\/s41467-026-71792-3","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:49:21Z","timestamp":1776156561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sphingosine-1-Phosphate-derived 2-Hexadecenal is a central mediator of ocular neovascularization by inhibiting Sphingosine-1-Phosphate receptor 5"],"prefix":"10.1038","volume":"17","author":[{"given":"Xin","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinteng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Bennewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Ast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2095-4437","authenticated-orcid":false,"given":"Glynis","family":"Klinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-0865","authenticated-orcid":false,"given":"Gernot","family":"Poschet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-4515","authenticated-orcid":false,"given":"Thomas","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-4962","authenticated-orcid":false,"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Szendroedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0908-2156","authenticated-orcid":false,"given":"Jens","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"71792_CR1","unstructured":"Organization, W. H. World report on vision. (2019)."},{"key":"71792_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","volume":"106","author":"RA Alshaikh","year":"2022","unstructured":"Alshaikh, R. A., Ryan, K. B. & Waeber, C. Sphingosine 1-phosphate, a potential target in neovascular retinal disease. Br. J. Ophthalmol. 106, 1187\u20131195 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"71792_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124\u2013136 (2010).","journal-title":"Lancet"},{"key":"71792_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60830-1","volume":"16","author":"TJ Lee","year":"2025","unstructured":"Lee, T. J. et al. Apolipoprotein M attenuates age-related macular degeneration phenotypes via sphingosine-1-phosphate signaling and lysosomal lipid catabolism. Nat. Commun. 16, 5331 (2025).","journal-title":"Nat. Commun."},{"key":"71792_CR5","doi-asserted-by":"crossref","unstructured":"Sorenson, C. M. et al. Fingolimod (FTY720), a sphinogosine-1-phosphate receptor agonist, mitigates choroidal endothelialproangiogenic properties and choroidal neovascularization. Cells 11, 969 (2022).","DOI":"10.3390\/cells11060969"},{"key":"71792_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","volume":"23","author":"K Gaengel","year":"2012","unstructured":"Gaengel, K. et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell 23, 587\u2013599 (2012).","journal-title":"Dev. Cell"},{"key":"71792_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-020-00215-1","volume":"10","author":"SJ Sonne","year":"2020","unstructured":"Sonne, S. J. & Smith, B. T. Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis. J. Ophthalmic. Inflamm. Infect. 10, 24 (2020).","journal-title":"J. Ophthalmic. Inflamm. Infect."},{"key":"71792_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.exer.2008.07.012","volume":"88","author":"S Caballero","year":"2009","unstructured":"Caballero, S. et al. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp. Eye Res. 88, 367\u2013377 (2009).","journal-title":"Exp. Eye Res."},{"key":"71792_CR9","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","volume":"50","author":"N Bartke","year":"2009","unstructured":"Bartke, N. & Hannun, Y. A. Bioactive sphingolipids: metabolism and function. J. Lipid Res. 50, S91\u2013S96 (2009).","journal-title":"J. Lipid Res."},{"key":"71792_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/LPI.S24081","volume":"8","author":"O Shadyro","year":"2015","unstructured":"Shadyro, O., Lisovskaya, A., Semenkova, G., Edimecheva, I. & Amaegberi, N. Free-radical destruction of sphingolipids resulting in 2-hexadecenal formation. Lipid Insights 8, 1\u20139 (2015).","journal-title":"Lipid Insights"},{"key":"71792_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cbf.3400","volume":"37","author":"NV Amaegberi","year":"2019","unstructured":"Amaegberi, N. V. et al. 2-Hexadecenal inhibits growth of C6 glioma cells. Cell Biochem. Funct. 37, 281\u2013289 (2019).","journal-title":"Cell Biochem. Funct."},{"key":"71792_CR12","doi-asserted-by":"publisher","first-page":"158681","DOI":"10.1016\/j.bbalip.2020.158681","volume":"1865","author":"DL Ebenezer","year":"2020","unstructured":"Ebenezer, D. L. et al. S1P and plasmalogen derived fatty aldehydes in cellular signaling and functions. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1865, 158681 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"71792_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12013-021-01005-9","volume":"79","author":"DL Ebenezer","year":"2021","unstructured":"Ebenezer, D. L. et al. Nuclear sphingosine-1-phosphate lyase generated \u22062-hexadecenal is a regulator of HDAC activity and chromatin remodeling in lung epithelial cells. Cell Biochem. Biophys. 79, 575\u2013592 (2021).","journal-title":"Cell Biochem. Biophys."},{"key":"71792_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cellsig.2011.02.009","volume":"23","author":"A Kumar","year":"2011","unstructured":"Kumar, A., Byun, H. S., Bittman, R. & Saba, J. D. The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cell Signal 23, 1144\u20131152 (2011).","journal-title":"Cell Signal"},{"key":"71792_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-022-01117-w","volume":"81","author":"GN Semenkova","year":"2023","unstructured":"Semenkova, G. N. et al. 2-Hexadecenal regulates ROS production and induces apoptosis in polymorphonuclear leucocytes. Cell Biochem. Biophys. 81, 77\u201386 (2023).","journal-title":"Cell Biochem. Biophys."},{"key":"71792_CR16","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1021\/ac501677y","volume":"86","author":"C Neuber","year":"2014","unstructured":"Neuber, C., Schumacher, F., Gulbins, E. & Kleuser, B. Method to simultaneously determine the sphingosine 1-phosphate breakdown product (2E)-hexadecenal and its fatty acid derivatives using isotope-dilution HPLC-electrospray ionization-quadrupole\/time-of-flight mass spectrometry. Anal. Chem. 86, 9065\u20139073 (2014).","journal-title":"Anal. Chem."},{"key":"71792_CR17","doi-asserted-by":"publisher","first-page":"24736","DOI":"10.1074\/jbc.M114.571869","volume":"289","author":"T Wakashima","year":"2014","unstructured":"Wakashima, T., Abe, K. & Kihara, A. Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation. J. Biol. Chem. 289, 24736\u201324748 (2014).","journal-title":"J. Biol. Chem."},{"key":"71792_CR18","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.redox.2020.101723","volume":"37","author":"B Lou","year":"2020","unstructured":"Lou, B. et al. Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans. Redox Biol. 37, 101723 (2020).","journal-title":"Redox Biol."},{"key":"71792_CR19","doi-asserted-by":"publisher","first-page":"e2302325","DOI":"10.1002\/advs.202302325","volume":"11","author":"X Qian","year":"2024","unstructured":"Qian, X. et al. Impaired detoxification of trans, trans-2,4-decadienal, an oxidation product from omega-6 fatty acids, alters insulin signaling, gluconeogenesis and promotes microvascular disease. Adv. Sci. 11, e2302325 (2024).","journal-title":"Adv. Sci."},{"key":"71792_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-4165(96)00126-2","volume":"1335","author":"TL Kelson","year":"1997","unstructured":"Kelson, T. L., Secor McVoy, J. R. & Rizzo, W. B. Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization. Biochim. Biophys. Acta 1335, 99\u2013110 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"71792_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.bbalip.2013.05.007","volume":"1831","author":"T Kitamura","year":"2013","unstructured":"Kitamura, T. et al. Substrate specificity, plasma membrane localization, and lipid modification of the aldehyde dehydrogenase ALDH3B1. Biochim. Biophys. Acta 1831, 1395\u20131401 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"71792_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molcel.2012.04.033","volume":"46","author":"K Nakahara","year":"2012","unstructured":"Nakahara, K. et al. The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. Mol. Cell 46, 461\u2013471 (2012).","journal-title":"Mol. Cell"},{"key":"71792_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/humu.24236","volume":"42","author":"M Rajeshwari","year":"2021","unstructured":"Rajeshwari, M. et al. Novel ALDH3A2 mutations in structural and functional domains of FALDH causing diverse clinical phenotypes in Sjogren-Larsson syndrome patients. Hum. Mutat. 42, 1015\u20131029 (2021).","journal-title":"Hum. Mutat."},{"key":"71792_CR24","volume":"30","author":"WB Rizzo","year":"2022","unstructured":"Rizzo, W. B., S\u2019Aulis, D., Dorwart, E. & Bailey, Z. Sjogren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents. Mol. Genet. Metab. Rep. 30, 100839 (2022).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"71792_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2007.03.046","volume":"356","author":"SA Marchitti","year":"2007","unstructured":"Marchitti, S. A., Orlicky, D. J. & Vasiliou, V. Expression and initial characterization of human ALDH3B1. Biochem Biophys. Res. Commun. 356, 792\u2013798 (2007).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"71792_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep27224","volume":"6","author":"L Regazzoni","year":"2016","unstructured":"Regazzoni, L. et al. A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect. Sci. Rep. 6, 27224 (2016).","journal-title":"Sci. Rep."},{"key":"71792_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"71792_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","volume":"524","author":"D Tsikas","year":"2017","unstructured":"Tsikas, D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges. Anal. Biochem. 524, 13\u201330 (2017).","journal-title":"Anal. Biochem."},{"key":"71792_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"71792_CR30","doi-asserted-by":"publisher","first-page":"1044213","DOI":"10.3389\/fnins.2022.1044213","volume":"16","author":"H Qi","year":"2022","unstructured":"Qi, H. et al. Acrolein-inducing ferroptosis contributes to impaired peripheral neurogenesis in zebrafish. Front. Neurosci. 16, 1044213 (2022).","journal-title":"Front. Neurosci."},{"key":"71792_CR31","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.phrs.2020.104793","volume":"156","author":"E Jozefczuk","year":"2020","unstructured":"Jozefczuk, E., Guzik, T. J. & Siedlinski, M. Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology. Pharm. Res. 156, 104793 (2020).","journal-title":"Pharm. Res."},{"key":"71792_CR32","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1515\/bchm2.1969.350.2.1233","volume":"350","author":"W Stoffel","year":"1969","unstructured":"Stoffel, W., LeKim, D. & Sticht, G. Distribution and properties of dihydrosphingosine-1-phosphate aldolase (sphinganine-1-phosphate alkanal-lyase). Hoppe Seylers Z. Physiol. Chem. 350, 1233\u20131241 (1969).","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"71792_CR33","doi-asserted-by":"publisher","first-page":"9154","DOI":"10.1021\/acs.jmedchem.5b00928","volume":"58","author":"AD Hobson","year":"2015","unstructured":"Hobson, A. D. et al. Discovery of A-971432, an orally bioavailable selective sphingosine-1-phosphate receptor 5 (S1P5) agonist for the potential treatment of neurodegenerative disorders. J. Med. Chem. 58, 9154\u20139170 (2015).","journal-title":"J. Med. Chem."},{"key":"71792_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.03.040","volume":"169","author":"M Sauerland","year":"2021","unstructured":"Sauerland, M. et al. Kinetic assessment of Michael addition reactions of alpha, beta-unsaturated carbonyl compounds to amino acid and protein thiols. Free Radic. Biol. Med. 169, 1\u201311 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"71792_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32447-1","volume":"13","author":"E Lyapina","year":"2022","unstructured":"Lyapina, E. et al. Structural basis for receptor selectivity and inverse agonism in S1P(5) receptors. Nat. Commun. 13, 4736 (2022).","journal-title":"Nat. Commun."},{"key":"71792_CR36","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/hmg\/ddad007","volume":"32","author":"J Collin","year":"2023","unstructured":"Collin, J. et al. Single-cell RNA sequencing reveals transcriptional changes of human choroidal and retinal pigment epithelium cells during fetal development, in healthy adult and intermediate age-related macular degeneration. Hum. Mol. Genet. 32, 1698\u20131710 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"71792_CR37","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.cell.2020.08.013","volume":"182","author":"CS Cowan","year":"2020","unstructured":"Cowan, C. S. et al. Cell types of the human retina and its organoids at single-cell resolution. Cell 182, 1623\u20131640 e1634 (2020).","journal-title":"Cell"},{"key":"71792_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/gm315","volume":"4","author":"AM Newman","year":"2012","unstructured":"Newman, A. M. et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 4, 16 (2012).","journal-title":"Genome Med."},{"key":"71792_CR39","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1167\/iovs.19-26767","volume":"60","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Induced expression of VEGFC, ANGPT, and EFNB2 and their receptors characterizes neovascularization in proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 60, 4084\u20134096 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"71792_CR40","doi-asserted-by":"publisher","first-page":"757607","DOI":"10.3389\/fimmu.2021.757607","volume":"12","author":"SK Boneva","year":"2021","unstructured":"Boneva, S. K. et al. In-depth molecular characterization of neovascular membranes suggests a role for hyalocyte-to-myofibroblast transdifferentiation in proliferative diabetic retinopathy. Front. Immunol. 12, 757607 (2021).","journal-title":"Front. Immunol."},{"key":"71792_CR41","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1167\/iovs.14-15589","volume":"56","author":"K Ishikawa","year":"2015","unstructured":"Ishikawa, K. et al. Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 56, 932\u2013946 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"71792_CR42","doi-asserted-by":"publisher","first-page":"102249","DOI":"10.1016\/j.redox.2022.102249","volume":"50","author":"DP Wohlfart","year":"2022","unstructured":"Wohlfart, D. P. et al. Accumulation of acetaldehyde in aldh2.1(-\/-) zebrafish causes increased retinal angiogenesis and impaired glucose metabolism. Redox Biol. 50, 102249 (2022).","journal-title":"Redox Biol."},{"key":"71792_CR43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tem.2019.05.005","volume":"30","author":"CJ Tian","year":"2019","unstructured":"Tian, C. J. & Zhen, Z. Reactive carbonyl species: diabetic complication in the heart and lungs. Trends Endocrinol. Metab. 30, 546\u2013556 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"71792_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.plaphy.2012.03.010","volume":"59","author":"J Mano","year":"2012","unstructured":"Mano, J. Reactive carbonyl species: their production from lipid peroxides, action in environmental stress, and the detoxification mechanism. Plant Physiol. Biochem. 59, 90\u201397 (2012).","journal-title":"Plant Physiol. Biochem."},{"key":"71792_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00395-008-0769-1","volume":"104","author":"V Randriamboavonjy","year":"2009","unstructured":"Randriamboavonjy, V. et al. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes. Basic Res. Cardiol. 104, 333\u2013340 (2009).","journal-title":"Basic Res. Cardiol."},{"key":"71792_CR46","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.4103\/ijo.IJO_3724_20","volume":"69","author":"Ensari Delioglu","year":"2021","unstructured":"Delioglu, E. nsari, Ugurlu, E. N., Erdal, N., Malekghasemi, E. & Cagil, S. N. Evaluation of sphingolipid metabolism on diabetic retinopathy. Indian J. Ophthalmol. 69, 3376\u20133380 (2021).","journal-title":"Indian J. Ophthalmol."},{"key":"71792_CR47","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1167\/iovs.17-22544","volume":"59","author":"J Eresch","year":"2018","unstructured":"Eresch, J. et al. Sphingosine kinase 2 modulates retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 59, 653\u2013661 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"71792_CR48","doi-asserted-by":"publisher","unstructured":"Terao, R. et al. Light stress-induced increase of sphingosine 1-phosphate in photoreceptors and its relevance to retinal degeneration. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20153670 (2019).","DOI":"10.3390\/ijms20153670"},{"key":"71792_CR49","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1021\/acschembio.7b01063","volume":"13","author":"GK Jarugumilli","year":"2018","unstructured":"Jarugumilli, G. K. et al. Chemical probe to identify the cellular targets of the reactive lipid metabolite 2- trans-hexadecenal. ACS Chem. Biol. 13, 1130\u20131136 (2018).","journal-title":"ACS Chem. Biol."},{"key":"71792_CR50","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt, C. et al. Ferroptosis in health and disease. Redox Biol. 75, 103211 (2024).","journal-title":"Redox Biol."},{"key":"71792_CR51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41418-024-01350-1","volume":"31","author":"F Maremonti","year":"2024","unstructured":"Maremonti, F. et al. Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell Death Differ. 31, 1104\u20131112 (2024).","journal-title":"Cell Death Differ."},{"key":"71792_CR52","doi-asserted-by":"publisher","first-page":"1234824","DOI":"10.3389\/fendo.2023.1234824","volume":"14","author":"J Ouyang","year":"2023","unstructured":"Ouyang, J., Zhou, L. & Wang, Q. Spotlight on iron and ferroptosis: research progress in diabetic retinopathy. Front. Endocrinol. 14, 1234824 (2023).","journal-title":"Front. Endocrinol."},{"key":"71792_CR53","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1084\/jem.20090525","volume":"206","author":"CN Jenne","year":"2009","unstructured":"Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469\u20132481 (2009).","journal-title":"J. Exp. Med."},{"key":"71792_CR54","doi-asserted-by":"crossref","unstructured":"Evrard, M. et al. Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes. J. Exp. Med. 219, e20210116 (2022).","DOI":"10.1084\/jem.20210116"},{"key":"71792_CR55","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/eji.201343312","volume":"43","author":"E Debien","year":"2013","unstructured":"Debien, E. et al. S1PR5 is pivotal for the homeostasis of patrolling monocytes. Eur. J. Immunol. 43, 1667\u20131675 (2013).","journal-title":"Eur. J. Immunol."},{"key":"71792_CR56","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.jaci.2017.11.022","volume":"141","author":"A Drouillard","year":"2018","unstructured":"Drouillard, A. et al. S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate. J. Allergy Clin. Immunol. 141, 2265\u20132268 e2261 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"71792_CR57","doi-asserted-by":"publisher","first-page":"845673","DOI":"10.3389\/fcvm.2022.845673","volume":"9","author":"F Xiong","year":"2022","unstructured":"Xiong, F. et al. Plasma Exosomal S1PR5 and CARNS1 as Potential Non-invasive Screening Biomarkers of Coronary Heart Disease. Front. Cardiovasc. Med. 9, 845673 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"71792_CR58","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03227-6","volume":"592","author":"A Baeyens","year":"2021","unstructured":"Baeyens, A. et al. Monocyte-derived S1P in the lymph node regulates immune responses. Nature 592, 290\u2013295 (2021).","journal-title":"Nature"},{"key":"71792_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ni.3619","volume":"18","author":"V Fang","year":"2017","unstructured":"Fang, V. et al. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-gamma response. Nat. Immunol. 18, 15\u201325 (2017).","journal-title":"Nat. Immunol."},{"key":"71792_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","volume":"185","author":"A Huwiler","year":"2018","unstructured":"Huwiler, A. & Zangemeister-Wittke, U. The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives. Pharm. Ther. 185, 34\u201349 (2018).","journal-title":"Pharm. Ther."},{"key":"71792_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/jpet.122.001529","volume":"386","author":"RA Alshaikh","year":"2023","unstructured":"Alshaikh, R. A., Zaki, R. G. E., El Din, R. A. S., Ryan, K. B. & Waeber, C. Siponimod as a novel inhibitor of retinal angiogenesis: in vitro and in vivo evidence of therapeutic efficacy. J. Pharm. Exp. Ther. 386, 224\u2013241 (2023).","journal-title":"J. Pharm. Exp. Ther."},{"key":"71792_CR62","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1248\/bpb.b20-00580","volume":"44","author":"H Shioya","year":"2021","unstructured":"Shioya, H. et al. Preventive and therapeutic efficacy of ONO-4641, a selective agonist for sphingosine 1-phosphate receptor 1 and 5, in preclinical models of type 1 diabetes mellitus. Biol. Pharm. Bull. 44, 188\u2013196 (2021).","journal-title":"Biol. Pharm. Bull."},{"key":"71792_CR63","doi-asserted-by":"publisher","first-page":"1055087","DOI":"10.3389\/fimmu.2022.1055087","volume":"13","author":"T Yue","year":"2022","unstructured":"Yue, T. et al. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front. Immunol. 13, 1055087 (2022).","journal-title":"Front. Immunol."},{"key":"71792_CR64","doi-asserted-by":"publisher","first-page":"100940","DOI":"10.1016\/j.preteyeres.2021.100940","volume":"84","author":"WW Pan","year":"2021","unstructured":"Pan, W. W., Lin, F. & Fort, P. E. The innate immune system in diabetic retinopathy. Prog. Retin. Eye Res. 84, 100940 (2021).","journal-title":"Prog. Retin. Eye Res."},{"key":"71792_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253\u2013310 (1995).","journal-title":"Dev. Dyn."},{"key":"71792_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"ND Lawson","year":"2002","unstructured":"Lawson, N. D. & Weinstein, B. M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307\u2013318 (2002).","journal-title":"Dev. Biol."},{"key":"71792_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03465-9","volume":"22","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Semaglultide targets Spp1(+) microglia\/macrophage to attenuate neuroinflammation following perioperative stroke. J. Neuroinflamm. 22, 143 (2025).","journal-title":"J. Neuroinflamm."},{"key":"71792_CR68","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.xpro.2020.100206","volume":"1","author":"J Morgenstern","year":"2020","unstructured":"Morgenstern, J., Kliemank, E., Campos, M. C., Nawroth, P. & Fleming, T. Michaelis-menten kinetics measurements of aldo-keto reductases for various substrates in murine tissue. STAR Protoc. 1, 100206 (2020).","journal-title":"STAR Protoc."},{"key":"71792_CR69","doi-asserted-by":"publisher","unstructured":"Wiggenhauser, L. M., Kohl, K., Dietrich, N., Hammes, H. P. & Kroll, J. Studying diabetes through the eyes of a fish: microdissection, visualization, and analysis of the adult tg(fli:EGFP) zebrafish retinal vasculature. J. Vis. Exp. https:\/\/doi.org\/10.3791\/56674 (2017).","DOI":"10.3791\/56674"},{"key":"71792_CR70","doi-asserted-by":"crossref","unstructured":"Zang, L., Shimada, Y., Nishimura, Y., Tanaka, T. & Nishimura, N. Repeated blood collection for blood tests in adult zebrafish. J. Vis. Exp. 102, e53272 (2015).","DOI":"10.3791\/53272-v"},{"key":"71792_CR71","doi-asserted-by":"publisher","first-page":"869732","DOI":"10.3389\/fchem.2022.869732","volume":"10","author":"HM Gegner","year":"2022","unstructured":"Gegner, H. M. et al. Deep metabolic profiling assessment of tissue extraction protocols for three model organisms. Front. Chem. 10, 869732 (2022).","journal-title":"Front. Chem."},{"key":"71792_CR72","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71792-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:02:32Z","timestamp":1776160952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71792-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71792"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71792-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3488"}}